Lista de obras - Marie Boyd - Dominio Público Uruguay

A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.

artículo científico publicado en 2000

A human BRCA1 gene knockout

scientific article published in Nature

A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo

artículo científico publicado en 2007

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects

artículo científico publicado en 2004

Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

artículo científico publicado en 2005

Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.

artículo científico publicado en 2005

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution

artículo científico publicado en 2010

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

artículo científico publicado en 2005

Deletion of the dual specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival

artículo científico publicado en 2011

Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects

artículo científico publicado en 2013

Dosimetry of very high energy electrons (VHEE) for radiotherapy applications: using radiochromic film measurements and Monte Carlo simulations

artículo científico publicado en 2014

Emulsion technologies for multicellular tumour spheroid radiation assays

artículo científico publicado en 2015

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.

artículo científico publicado en 2000

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination

artículo científico publicado en 2008

Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.

artículo científico publicado en 2001

Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements

artículo científico publicado en 2019

Gene manipulation to enhance MIBG-targeted radionuclide therapy.

artículo científico publicado en 2005

Genetic enhancement of radionuclide cancer therapy

scientific article published on 01 December 1999

Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter

artículo científico publicado en 2012

Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers

artículo científico publicado en 2017

Laser-plasma generated very high energy electrons (VHEEs) in radiotherapy

Lysosomotropism depends on glucose: a chloroquine resistance mechanism

artículo científico

Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro.

artículo científico publicado en 2006

National symposium on low-dose radiation and bystander effects -12 October 2004, Cancer Research UK Beatson Laboratories, GlasgowSponsored by Glasgow University School for Cancer Studies, the Department of Health and the National Cancer Research Inst

article

New Sulphated Flavonoids from Wissadula periplocifolia (L.) C. Presl (Malvaceae).

artículo científico publicado en 2015

Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy.

artículo científico publicado en 2008

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

artículo científico publicado en 2006

Plasma Metabolomics Identifies Lipid and Amino Acid Markers of Weight Loss in Patients with Upper Gastrointestinal Cancer

artículo científico publicado en 2019

Preclinical Assessment of Strategies for Enhancement of Metaiodobenzylguanidine Therapy of Neuroendocrine Tumors ⬇️

artículo científico publicado el 1 de septiembre de 2011

Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma

artículo científico publicado en 2010

Radiation quality-dependent bystander effects elicited by targeted radionuclides

artículo científico publicado en 2008

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase.

artículo científico publicado en 2006

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species

artículo científico publicado en 2013

SU-E-T-472: Characterization of the Very High Energy Electrons, ISO - 250 MeV (VHEE) Beam Generated by ALPHA-X Laser Wakefield Accelerator Beam Line for Utilization in Monte Carlo Simulation for Biomedical Experiment Planning.

artículo científico publicado en 2012

Screening for molecular pathologies in Lesch-Nyhan syndrome

scientific article published on 01 January 1993

Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo

artículo científico publicado en 2015

Targeting Radiotherapy to Cancer by Gene Transfer

artículo científico publicado en 2003

Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy.

artículo científico publicado en 2002

Transitioning from multi-phase to single-phase microfluidics for long-term culture and treatment of multicellular spheroids

artículo científico publicado en 2016

Untargeted Metabolomics Profiling of an 80.5 km Simulated Treadmill Ultramarathon.

artículo científico publicado en 2018

[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma

artículo científico publicado en 2005

[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter

artículo científico publicado en 2005

p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.

artículo científico publicado en 2006

Lista de obras de Marie Boyd

A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.

A human BRCA1 gene knockout

A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects

Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

Deletion of the dual specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival

Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects

Dosimetry of very high energy electrons (VHEE) for radiotherapy applications: using radiochromic film measurements and Monte Carlo simulations

Emulsion technologies for multicellular tumour spheroid radiation assays

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination

Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.

Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements

Gene manipulation to enhance MIBG-targeted radionuclide therapy.

Genetic enhancement of radionuclide cancer therapy

Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter

Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers

Laser-plasma generated very high energy electrons (VHEEs) in radiotherapy

Lysosomotropism depends on glucose: a chloroquine resistance mechanism

Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro.

National symposium on low-dose radiation and bystander effects -12 October 2004, Cancer Research UK Beatson Laboratories, GlasgowSponsored by Glasgow University School for Cancer Studies, the Department of Health and the National Cancer Research Inst

New Sulphated Flavonoids from Wissadula periplocifolia (L.) C. Presl (Malvaceae).

Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy.

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

Plasma Metabolomics Identifies Lipid and Amino Acid Markers of Weight Loss in Patients with Upper Gastrointestinal Cancer

Preclinical Assessment of Strategies for Enhancement of Metaiodobenzylguanidine Therapy of Neuroendocrine Tumors ⬇️

Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma

Radiation quality-dependent bystander effects elicited by targeted radionuclides

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase.

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species

SU-E-T-472: Characterization of the Very High Energy Electrons, ISO - 250 MeV (VHEE) Beam Generated by ALPHA-X Laser Wakefield Accelerator Beam Line for Utilization in Monte Carlo Simulation for Biomedical Experiment Planning.

Screening for molecular pathologies in Lesch-Nyhan syndrome

Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo

Targeting Radiotherapy to Cancer by Gene Transfer

Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy.

Transitioning from multi-phase to single-phase microfluidics for long-term culture and treatment of multicellular spheroids

Untargeted Metabolomics Profiling of an 80.5 km Simulated Treadmill Ultramarathon.

[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma

[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter

p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.